SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

Avantis ($AVNT.X) is trending due to high volume and trader activity, with community members pointing to recent price gains and comparing it to other DeFi gainers. Conversations suggest excitement around its features, potential for new all-time highs, and speculation about hitting certain price targets.  Some users are also mentioning the project's backers and the possibility of listings on major exchanges.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors discuss the potential for a violent short squeeze, citing high short interest and borrow fees. Community members are focused on the upcoming Type A meeting minutes and HOPE-3 data, with some expressing concerns about the FDA's review process. Discussions also highlight the real-world impact of Capricor's therapy on patients' lives and the potential for FDA approval.

TOSHI

TOSHI.X is trending amid community excitement surrounding new listings on exchanges and potential partnerships, driving significant volume. The community is closely watching for a breakout, with many believing it has the potential to reach new all-time highs and drop a zero soon. Bullish sentiment is fueled by its association with Coinbase and the broader anticipation of altcoin season.

PHUMPTOM (PHUM) is a meme token, the symbol of which is a phantom. The story of this character is built around trading, and according to legend, he was born on the pump platform.fun from the energy of green candles. Now it is a symbol of green charts, the keeper of green candles. His presence portends growth, and he brings good luck to traders.  A positive character who tells his story like an adventure, generates memes where he always rushes to the aid of traders and gives good luck to holders.

PHUMPTOM

PHUM.X is gaining attention as a potential "sleeper gem" within the Solana ecosystem, with community members actively encouraging others to buy in early. The token is generating buzz, with many highlighting its chart strength and anticipating a breakout. Some users are also emphasizing the importance of teamwork and community support for the token's success.

"What's Updog?" is a Community Led token.

UpDog

$UPDOG.X is trending as the community rallies around this Solana-based meme coin and its 'Updog' namesake. Active discussions revolve around its strong community, long-term development, and potential for a meme-driven surge similar to other popular dog-themed tokens in the crypto space.

Story is a purpose-built layer 1 blockchain designed specifically to onramp intellectual property (IP) to the blockchain and make it programmable.  Story tokenizes any type of IP; whether that’s an idea, an image, a real world asset, a song, an AI model, an NFT or anything in-between. By embedding usage terms, attribution, and royalty agreements directly into the blockchain, Story provides a transparent, decentralized solution for IP management. This enables IP holders to protect their work, collaborate on IP seamlessly, and unlock revenue opportunities in an AI-powered economy.

Story Protocol

Story Protocol ($IP.X) is trending as traders discuss its potential in the AI and IP space, noting recent exchange listings and a limited coin supply. Community members are sharing bullish price predictions and analyzing technical indicators, while also drawing comparisons to other trending tokens like $KAITO.X. Some investors are excited about potential partnerships with major AI/robotics companies and upcoming announcements.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X ($CCCX) is trending due to its upcoming merger with Infleqtion, a quantum computing company, generating excitement as a potentially undervalued pure-play in the sector. The community is comparing it to other quantum stocks like $IONQ and $RGTI, while also highlighting Infleqtion's existing contracts and revenue. Some are also speculating about the potential of its warrants.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase is trending as discussions revolve around the potential impacts of President Trump's policies on visa holders and the company's response. Community members are also analyzing JPM's financials, with some suggesting it's overvalued and ripe for a pullback, while others highlight its strong earnings and potential for growth in various sectors. Additionally, the company's strategic moves, such as its Asia expansion, partnership with Plaid, and potential takeover of Apple's credit card program, are fueling investor interest and debate.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending due to discussions around increased Vazkepa prescriptions in England and a potential buyout following an updated corporate overview, sparking speculation about a deal with Novartis. The community is analyzing data suggesting strong growth in EU scripts and the implications of Sarissa's involvement, interpreting recent corporate actions as strategic positioning for acquisition. Analysts are pointing to the company's cash position, reduced expenses, and potential for revenue growth as positive factors, while highlighting both near and long-term catalysts.

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Dexcom Inc

Dexcom is trending following a short report alleging safety issues with its G7 glucose monitor, leading to a sharp sell-off and active debate among investors regarding the report's validity and the company's response. Community discussion revolves around potential management restructuring, the G7's user experience, and comparisons to competitors. Some are speculating about a potential overreaction and future rebound based on analyst forecasts and upcoming product launches.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Choice Hotels (CHH) Reports Q2 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Choice Hotels (CHH) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Choice Hotels (CHH) Q2 Earnings Top Estimates

Choice Hotels (CHH) delivered earnings and revenue surprises of +1.05% and -0.15%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Hyatt Hotels (H) to Report a Decline in Earnings: What to Look Out for

Hyatt Hotels (H) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Choice Hotels (CHH) Earnings Expected to Grow: Should You Buy?

Choice Hotels (CHH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Civeo (CVEO) Reports Q2 Loss, Lags Revenue Estimates

Civeo (CVEO) delivered earnings and revenue surprises of -733.33% and -1.60%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Hilton Worldwide (HLT) Moves 3.1% Higher: Will This Strength Last?

Hilton Worldwide (HLT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Choice Hotels on Expansion Spree, Expands Everhome Suites Nationwide

NuScale Posts Narrower Q1 Loss Y/Y With Revenue Growth, Stock Up

Choice Hotels (CHH) Lags Q1 Earnings and Revenue Estimates

Goldman Sachs recommends Choice Hotels, cuts Hyatt amid weaker US lodging outlook

Investing.com --Goldman Sachs has a dour outlook on U.S. lodging companies, citing weakening consumer demand, geopolitical uncertainty, and a negative read-across from U.S. airlines. In turn, Goldman is shifting its stock preferences, favoring asset-light operators with global diversity and less exposure to U.S. resort markets and incentive management fees. The firm upgraded Choice Hotels (NYSE:CHH) from Sell to Buy, while Hyatt was downgraded from Neutral to Sell. Marriott and Hilton were both cut to Neutral, while Wyndham remains a Buy. Lodging stocks have underperformed in recent months, with Hyatt down 32%, Marriott off 27%, and Hilton falling 21%, compared to a 13% decline in the S&P 500. Airline warnings on domestic demand, alongside weaker foreign arrivals after new tariff announcements, add to pressure on the sector.

Choice Hotels International, Inc. engages in the franchising and operations of hotels. It operates through the Hotel Franchising, and Corporate and Other segments. The Hotel Franchising segment refers to the hotel franchising operations consisting of the company's several hotel brands. The Corporate and Other segment deals with hotel revenues and rental income related to office buildings owned by the company. The company was founded in 1939 and is headquartered in North Bethesda, MD.

Choice Hotels International, Inc.

Just the one

Three

Four

The Fed just cut rates. How many cuts do you expect in all of 2025? 
 
*Powered by Polymarket

Current Price	$110.91
Prev Close	$109.86
Open	$109.85
Dividend Yield	0.81%
50-Day Moving Average	$122.65
Beta	0.77
Avg. Volume	424,845.43
PE Ratio	17.02

52-Week High	$157.86
52-Week Low	$109.33
Market Capitalization	$5.13B
EPS (Annual)	$6.20
Price to Book	-195.56
Revenue Per Employee	$935,008.26
Enterprise Value/EBITDA	N/A

CHH
Choice Hotels International, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CHH News

CHH Choice Hotels International, Inc.